Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors

被引：2
|
作者：
Song, Jiho [1 ]
Lee, Jung Wook [1 ]
Chung, Shin Hyuck [1 ]
Wenas, Michelle A. [1 ]
Min, Kyung Hoon [1 ]
机构：
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
来源：
BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2017年 / 38卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
EGFR; VEGFR-2; Tyrosine kinase inhibitors; Pyrimidine; GROWTH-FACTOR RECEPTOR; BEVACIZUMAB; ERLOTINIB; CANCER; RESISTANCE; THERAPY; CELL;
D O I：
10.1002/bkcs.11278
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1255 / 1256
页数：2
相关论文
共 50 条
  • [41] RING TRANSFORMATIONS OF PYRIMIDINES BY ACTION OF NUCLEOPHILES .4. CONVERSION OF 4,6-DISUBSTITUTED PYRIMIDINES INTO 1,2,4-TRIAZOLES BY ACTION OF HYDRAZINE
    VANDERPLAS, HC
    JONGEJAN, H
    RECUEIL DES TRAVAUX CHIMIQUES DES PAYS-BAS, 1970, 89 (07): : 680 - +
  • [42] STRUCTURE-ACTIVITY STUDIES OF 4,6-DISUBSTITUTED 2-(MORPHOLINOCARBONYL)FURO[3,2-B]INDOLE DERIVATIVES WITH ANALGESIC AND ANTIINFLAMMATORY ACTIVITIES
    KAWASHIMA, Y
    AMANUMA, F
    SATO, M
    OKUYAMA, S
    NAKASHIMA, Y
    SOTA, K
    MORIGUCHI, I
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (11) : 2284 - 2290
  • [43] Identification of new pyrrolo [2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling
    Adel, Mai
    Serya, Rabah A. T.
    Lasheen, Deena S.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2018, 81 : 612 - 629
  • [44] Identification and structure-activity relationships of 2,6-disubstituted pyrazines as antituberculosis agents
    Sun, Yongmao
    Petukhova, Valentina
    Giri, Rajan S.
    Klein, Larry L.
    Song, Yang
    Zhang, Nan
    Peng, Kuan Wei
    Wan, Baojie
    Wang, Yuehong
    Franzblau, Scott G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [45] Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review
    Metwally, Kamel
    Abo-Dya, Nader E.
    CURRENT MEDICINAL CHEMISTRY, 2023, 31 (36) : 5918 - 5936
  • [46] Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
    Li, Yunqi
    Tan, Chunyan
    Gao, Chunmei
    Zhang, Cunlong
    Luan, Xudong
    Chen, Xiaowu
    Liu, Hongxia
    Chen, Yuzong
    Jiang, Yuyang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) : 4529 - 4535
  • [47] Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
    El-Naggar, Abeer M.
    Hassan, A. M. A.
    Elkaeed, Eslam B.
    Alesawy, Mohamed S.
    Al-Karmalawy, Ahmed A.
    BIOORGANIC CHEMISTRY, 2022, 123
  • [48] Structure-Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017-Present)
    Sandor, Alexandru
    Ionut, Ioana
    Marc, Gabriel
    Oniga, Ilioara
    Eniu, Dan
    Oniga, Ovidiu
    PHARMACEUTICALS, 2023, 16 (04)
  • [49] Synthesis and structure-activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitors
    Xu, Yong
    Foulks, Jason M.
    Clifford, Adrianne
    Brenning, Benjamin
    Lai, Shuping
    Luo, Bai
    Parnell, K. Mark
    Merx, Shannon
    McCullar, Michael V.
    Kanner, Steven B.
    Ho, Koc-Kan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4072 - 4075
  • [50] Quantitative structure-activity relationships (QSAR):: studies of inhibitors of tyrosine kinase
    Shen, Q
    Lü, QZ
    Jiang, JH
    Shen, GL
    Yu, RQ
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 20 (01) : 63 - 71
12345